Literature DB >> 32294550

Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma.

Xin Huang1, Jing Chen2, Wei Wu1, Wenbo Yang1, Binlong Zhong1, Xiangcheng Qing3, Zengwu Shao4.   

Abstract

Photodynamic therapy (PDT) generates highly toxic reactive oxygen species (ROS) during noninvasive cancer treatment. MutT homolog 1 (MTH1) protein is a DNA oxidative damage repair protease and suppressing its function may provide a strategy to enhance PDT efficacy by improving cellular sensitivity to ROS. A nanoparticle, composed of functional graphene oxide (GO) conjugated with polyethylene glycol (PEG), folic acid (FA) and photosensitizer indocyanine green (ICG), was constructed to deliver MTH1 inhibitor (TH287) and doxorubicin. The effects of this nanoparticle on biological properties and cell death of osteosarcoma cells were investigated. We further examined the endoplasmic reticulum (ER) stress and apoptosis in osteosarcoma. A xenograft tumor model was used to validate the results in vivo. This drug-carrying PEG-GO-FA/ICG nanoparticle showed combined chemo-photodynamic therapy (Chemo-PDT) to inhibit the proliferation and migration of osteosarcoma cells. Enhanced Chemo-PDT promoted both apoptosis and autophagy by suppressing the MTH1 protein and promoting the accumulation of ROS. In this study, autophagy served as a rescue pathway against cell death, and suppressing autophagy enhanced the anti-cancer effects of Chemo-PDT. However, Chemo-PDT induced apoptosis was related to the occurrence of ER stress. ROS might contribute to ER stress and further induce apoptosis via the JNK/p53/p21 pathway. These findings provide a mechanistic understanding of nanoparticle-induced cell death in osteosarcoma. The combination of Chemo-PDT with other therapies is promising as a new strategy to treat osteosarcoma. STATEMENT OF SIGNIFICANCE: Administration of chemotherapeutic drugs by traditional methods still has many problems. We designed a functionalized graphene oxide drug delivery system to deliver the photosensitizer indocyanine green, doxorubicin, and MTH1 inhibitor TH287. This nano delivery system showed combined chemo-photodynamic effects to inhibit osteosarcoma. Suppressing MTH1 protein might induce "phenotypic lethality" and enhance chemo-photodynamic therapy efficacy by improving cellular sensitivity to reactive oxygen species.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Chemo-photodynamic therapy; Graphene oxide; MTH1; Osteosarcoma

Mesh:

Substances:

Year:  2020        PMID: 32294550     DOI: 10.1016/j.actbio.2020.04.009

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  12 in total

1.  NR4A1 enhances MKP7 expression to diminish JNK activation induced by ROS or ER-stress in pancreatic β cells for surviving.

Authors:  Ze-Qing Pu; Tian-Fu Yu; Dong Liu; Cheng-Wen Jin; Esha Sadiq; Xiaofei Qiao; Xiaojie Li; Yuxuan Chen; Jinsong Zhang; Mingzhong Tian; Siying Li; Ru-Xing Zhao; Xiang-Dong Wang
Journal:  Cell Death Discov       Date:  2021-06-04

2.  Graphene Oxide Nanoparticle-Loaded Ginsenoside Rg3 Improves Photodynamic Therapy in Inhibiting Malignant Progression and Stemness of Osteosarcoma.

Authors:  Shou-Liang Lu; Yan-Hua Wang; Guang-Fei Liu; Lu Wang; Yong Li; Zhi-Yuan Guo; Cai Cheng
Journal:  Front Mol Biosci       Date:  2021-04-22

Review 3.  Autophagy Regulation and Photodynamic Therapy: Insights to Improve Outcomes of Cancer Treatment.

Authors:  Waleska K Martins; Renata Belotto; Maryana N Silva; Daniel Grasso; Maynne D Suriani; Tayná S Lavor; Rosangela Itri; Mauricio S Baptista; Tayana M Tsubone
Journal:  Front Oncol       Date:  2021-01-20       Impact factor: 6.244

4.  Amphiphilic block polymer-based self-assembly of high payload nanoparticles for efficient combinatorial chemo-photodynamic therapy.

Authors:  Qisan Ma; Yanna Zhao; Qingran Guan; Yuping Zhao; Huaizhen Zhang; Zhuang Ding; Qingpeng Wang; Yushu Wu; Min Liu; Jun Han
Journal:  Drug Deliv       Date:  2020-11-16       Impact factor: 6.419

Review 5.  Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies.

Authors:  Sepideh Mirzaei; Kiavash Hushmandi; Amirhossein Zabolian; Hossein Saleki; Seyed Mohammad Reza Torabi; Adnan Ranjbar; SeyedHesam SeyedSaleh; Seyed Omid Sharifzadeh; Haroon Khan; Milad Ashrafizadeh; Ali Zarrabi; Kwang-Seok Ahn
Journal:  Molecules       Date:  2021-04-19       Impact factor: 4.411

6.  Targeting GRP78 enhances the sensitivity of HOS osteosarcoma cells to pyropheophorbide-α methyl ester-mediated photodynamic therapy via the Wnt/β-catenin signaling pathway.

Authors:  Qiang Zuo; Yunsheng Ou; Shenxi Zhong; Haoyang Yu; Fangbiao Zhan; Muzi Zhang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2021-10-12       Impact factor: 3.848

Review 7.  Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma.

Authors:  Kunzhe Wu; Beibei Yu; Di Li; Yangyang Tian; Yan Liu; Jinlan Jiang
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

Review 8.  Development of Graphene-Based Materials in Bone Tissue Engineaering.

Authors:  Xiaoling Pan; Delin Cheng; Changshun Ruan; Yonglong Hong; Cheng Lin
Journal:  Glob Chall       Date:  2021-12-02

Review 9.  Molecular Effectors of Photodynamic Therapy-Mediated Resistance to Cancer Cells.

Authors:  Eric Chekwube Aniogo; Blassan P George; Heidi Abrahamse
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

10.  Amplification of oxidative stress with lycorine and gold-based nanocomposites for synergistic cascade cancer therapy.

Authors:  Hongzhi Hu; Wenbo Yang; Zihui Liang; Zezhu Zhou; Qingcheng Song; Weijian Liu; Xiangtian Deng; Jian Zhu; Xin Xing; Binglong Zhong; Baichuan Wang; Shangyu Wang; Zengwu Shao; Yingze Zhang
Journal:  J Nanobiotechnology       Date:  2021-07-27       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.